MAPT and Alzheimer disease: Therefore, our data strongly support that C/EBPβ escalates the expression of delta-secretase, and triggers APP and Tau cleavage by delta-secretase, ultimately leading to neuronal cell loss and earlier onset of AD-like pathogenesis in 3xTg and exacerbation of cognitive impairments.